Zheng Wang - Concepedia

Author

Zheng Wang

Capital Medical University ORCID

Also Known As

Wang, Zheng, Yu‐Qing Liu, Z-C Wang, Z.-C. Wang, ZHENG WANG, Zheng Wang

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Capital Medical University Beijing Tian Tan Hospital Beijing Institute of Neurosurgery Chinese Institute for Brain Research National Clinical Research Center for Digestive Diseases

About

Zheng Wang is an author at Capital Medical University specializing in medicine, glioma, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.5K
2	Engineering	4	4	1.2K
3	Health Sciences	1	1	105
4	Natural Sciences	1	1	30
5	Biology	1	1	30

Zheng Wang

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients Zheng Zhao, Kenan Zhang, Qiangwei Wang, Genomics Proteomics & Bioinformatics EngineeringPathologyFunctional Genomic DataHigh-grade GliomasBioinformatics Database	2021	1K
Tumor Purity as an Underlying Key Factor in Glioma Chuanbao Zhang, Wen Cheng, Xiufang Ren, Clinical Cancer Research	2017	428
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas Barbara Oldrini, Nuria Vaquero‐Siguero, Quanhua Mu, Nature Communications	2020	188
Genetic and clinical characterization of B7‐H3 (CD276) expression and epigenetic regulation in diffuse brain glioma Zhiliang Wang, Zheng Wang, Chuanbao Zhang, Cancer Science	2018	105
Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data for Chinese Glioma Patients Zheng Zhao, Kenan Zhang, Qiangwei Wang, PathologyFunctional Genomic DataMultiomicsHigh-grade GliomasGlioma	2020	105
Relationship between necrotic patterns in glioblastoma and patient survival: fractal dimension and lacunarity analyses using magnetic resonance imaging Shuai Liu, Yinyan Wang, Kaibin Xu, Scientific Reports Lacunarity AnalysesEngineeringCell DeathPathologyHigh-grade Gliomas	2017	87
IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma Ailiang Zeng, Qi Hu, Yanwei Liu, Oncotarget	2015	76
ISG20 promotes local tumor immunity and contributes to poor survival in human glioma Mengqi Gao, Yi Lin, Xing Liu, OncoImmunology ImmunologyCell DeathPathologyHigh-grade GliomasCancer Biology	2018	75
Amino acid metabolism‐related gene expression‐based risk signature can better predict overall survival for glioma Yu‐Qing Liu, Ruichao Chai, Yongzhi Wang, Cancer Science	2018	70
IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 311 Chinese adult glioma patients Zhang Zhong, Zheng Wang, Yinyan Wang, Epilepsy Research Neuro-oncologyNeurological DisorderPathologyInitial SymptomNeurology	2014	68

Page 1